1H-Benzimidazole-1-carboxylic acid, 6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester, identified by CAS number 631912-39-5, is a complex organic compound characterized by its benzimidazole core, which is a bicyclic structure containing a fused benzene and imidazole ring. This compound features a carboxylic acid functional group, which is typically acidic and can participate in various chemical reactions, including esterification. The presence of a dioxaborolane moiety suggests potential applications in boron chemistry, particularly in organoboron compounds used for cross-coupling reactions in organic synthesis. The tert-butyl ester group enhances the compound's lipophilicity, potentially improving its solubility in organic solvents and biological systems. Additionally, the methyl substituents on the benzimidazole ring can influence the compound's electronic properties and steric hindrance, affecting its reactivity and interactions with biological targets. Overall, this compound may have applications in medicinal chemistry, particularly in the development of pharmaceuticals or agrochemicals.

1H-BenziMidazole-1-carboxylic acid, 6-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-diMethylethyl ester

631912-39-5: 1H-Benzimidazole-1-carboxylic acid, 6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester, identified by CAS number 631912-39-5, is a complex organic compound characterized by its benzimidazole core, which is a bicyclic structure containing a fused benzene and imidazole ring. This compound features a carboxylic acid functional group, which is typically acidic and can participate in various chemical reactions, including esterification. The presence of a dioxaborolane moiety suggests potential applications in boron chemistry, particularly in organoboron compounds used for cross-coupling reactions in organic synthesis. The tert-butyl ester group enhances the compound's lipophilicity, potentially improving its solubility in organic solvents and biological systems. Additionally, the methyl substituents on the benzimidazole ring can influence the compound's electronic properties and steric hindrance, affecting its reactivity and interactions with biological targets. Overall, this compound may have applications in medicinal chemistry, particularly in the development of pharmaceuticals or agrochemicals.

tert-Butyl 6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate

tert-Butyl 6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole-1-carboxylate

CAS 631912-39-5

1H-BenziMidazole-1-carboxylic acid, 6-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-diMethylethyl ester

tert-Butyl 6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole-1-carboxylate

Ref: IN-DA00EKKE

tert-Butyl 6-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole-1-carboxylate

Ref: 54-OR305022